Please assess the completion status of the following clinical trial:

Trial Title: MK0507A Clinical Study in Patients With Glaucoma and Ocular Hypertension (0507A-149)(COMPLETED)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with glaucoma and ocular hypertension~Exclusion Criteria:~* History of ocular surgery within 3 months~* Administration contradiction to timolol and dorzolamide

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): combination of dorzolamide hydrochloride and timolol maleate
- 2 (Type: ACTIVE_COMPARATOR): Concomitant use of dorzolamide hydrochloride and timolol maleate
- 3 (Type: ACTIVE_COMPARATOR): timolol maleate

Based on this trial design, predict the completion outcome and termination type (if applicable).